Contemporary Oncology
eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
4/2025
vol. 29
 
Share:
Send email
Share:
Original paper

Clinical outcomes of fractionated stereotactic radiotherapy for uveal melanoma – a Polish single-centre experience

Adam Deja
1
,
Paulina Baluch
2
,
Marta Wróblewska-Zierhoffer
2
,
Emilia Zwolińska
2
,
Maria Radomiak
1
,
Piotr Milecki
1
,
Iwona Rospond-Kubiak
2

  1. The Maria Skłodowska-Curie Greater Poland Cancer Centre, Poznań, Poland
  2. Department of Ophthalmology, Poznań University of Medical Sciences, Poznań, Poland
Contemp Oncol (Pozn) 2025; 29 (4): 367–369
DOI: https://doi.org/10.5114/wo.2025.155789
Online publish date: 2025/11/03
Article file
- Clinical outcomes.pdf  [0.06 MB]
Get citation
 
PlumX metrics:
 
1. Van Beek JGM, van Rij CM, Baart SJ, Yavuzyigitoglu S, Bergmann MJ, Paridaens D, et al. Fractionated stereotactic radiotherapy for uveal melanoma: long-term outcome and control rates. Acta Ophthalmol 2022; 100: 511-519.
2. Van Beek JGM, Buitendijk GHS, Timman R, Muller K, Luyten GPM, Paridaens D, et al. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients. Acta Ophthalmol 2018; 96: 841-848.
3. Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods 2020; 17: 261-272
4. Özcan G, Gündüz AK, Mirzayev İ, Oysul K, Uysal H. Early results of stereotactic radiosurgery in uveal melanoma and risk factors for radiation retinopathy. Turk J Ophthalmol 2020; 50: 156-162.
5. Hirasawa N, Tsuji H, Ishikawa H, Koyama-Ito H, Kamada T, Mi- zoe JE, et al. Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2007; 67: 538-543.
6. Kosydar S, Robertson JC, Woodfin M, Mayr NA, Sahgal A, Timmerman RD, et al. Systematic review and meta-analysis on the use of photon-based stereotactic radiosurgery versus fractionated stereotactic radiotherapy for the treatment of uveal melanoma. Am J Clin Oncol 2021; 44: 32-42.
7. Van Beek JGM, Jackelien GM, van Rij CM, Baart SJ, Paridaens D, van den Bosch WA, et al. Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam radiotherapy in uveal melanoma. Radiother Oncol 2021; 157: 219-224.
8. Laliscia C, Perrone F, Guido F, Cresti F, Fuentes T, Paiar F et al. A cohort of long-surviving patients affected by small and medium uveal melanoma treated with ruthenium-106 plaque brachytherapy. Contemp Oncol 2024; 28: 318-325.
9. Sagoo MS, Shields CL, Emrich J, Mashayekhi A, Komarnicky L, Shields JA. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases. JAMA Ophthalmol 2014; 132: 697-702.
10. Finger PT, Chin KJ, Semenova EA. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study. Eur J Ophthalmol 2016; 26: 60-66.
Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.